Chirogate is a professional Prostaglandin manufacturer.
01 1Chirogate International Inc.
02 1AGC Inc.
03 1YS Life Science Co. , Ltd.
01 2Tafluprost
02 1Tafluprost
01 1Japan
02 1South Korea
03 1Taiwan
Registration Number : 303MF10019
Registrant's Address : No. 2, Shih 4th Rd. , Yangmei Dist. , Taoyuan City 326013, Taiwan
Initial Date of Registration : 2021-01-26
Latest Date of Registration : 2022-11-09
Registration Number : 218MF10584
Registrant's Address : 1-5-1 Marunouchi, Chiyoda-ku, Tokyo
Initial Date of Registration : 2006-06-22
Latest Date of Registration : 2014-07-01
Tafluprost "For manufacturing purposes only"
Registration Number : 304MF10024
Registrant's Address : 207, Sujeong-ro, Jangan-myeon, Hwaseong-si, Gyeonggi-do, 18581, Republic of Korea
Initial Date of Registration : 2022-02-02
Latest Date of Registration : 2022-02-02
A Tafluprost manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tafluprost, including repackagers and relabelers. The FDA regulates Tafluprost manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tafluprost API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tafluprost manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tafluprost supplier is an individual or a company that provides Tafluprost active pharmaceutical ingredient (API) or Tafluprost finished formulations upon request. The Tafluprost suppliers may include Tafluprost API manufacturers, exporters, distributors and traders.
click here to find a list of Tafluprost suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tafluprost Drug Master File in Japan (Tafluprost JDMF) empowers Tafluprost API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tafluprost JDMF during the approval evaluation for pharmaceutical products. At the time of Tafluprost JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tafluprost suppliers with JDMF on PharmaCompass.
We have 3 companies offering Tafluprost
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?